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PATIENTS’ USE OF INFORMATION SOURCES REGARDING SIDE EFFECTS 
B O’Donovan1, RM Rodgers1, AR Cox2, J Krska1 
1 - Medway School of Pharmacy, Universities of Greenwich and Kent 
2 – School of Pharmacy, University of Birmingham 
 
Background: Medicine side effects are common, but little is known about the different information 
sources patients use in identifying suspected side effects and how these are perceived. 
Aim: To determine the perceived value and use of different information sources to support side 
effect identification.  
Method: NHS Ethics approval was granted. A questionnaire was developed and piloted which 
covered likely use of information sources, plus views on their ease of access, trustworthiness and 
ease of understanding; experiences of side effects and actual use of information sources in relation 
to these; and respondent confidence in the association. The questionnaire was distributed to adult 
customers of pharmacies in Kent and Birmingham, using prescription or non-prescribed medicines in 
the past six months. Chi-squared tests were used to assess associations and missing data excluded 
from analysis. 
Results: A total of 894 questionnaires were distributed and 230 returned (25.7% response rate). 
Over half the respondents were female (141; 61.3%), 73 (32.0%) were aged below 50, 99 (43.4%) 51 
to 70 and 56 (24.6%) above 70 years. Most (193; 84.6%) used at least one medicine regularly and 
160 (69.6%) indicated they had experienced at least one side effect from a medicine. Information 
sources respondents indicated most frequently they would use to find out about a side effect were 
patient information leaflets (PILs) (194; 85.1%), GPs (192; 84.2%), pharmacists (153; 67.1%), the 
internet (123; 55.3%) and relatives/friends (73; 32.0%). 
While most respondents (180; 78.3%) thought PILs easy to access, fewer considered them 
trustworthy (135; 59.0%) and 124 (54.1%) easy to understand. In contrast, most people (181; 79.0%) 
considered GPs trustworthy information sources, but fewer thought them easy to access (95; 
41.5%). Pharmacists were judged both easy to access (175; 76.4%) and trustworthy (166; 72.5%). 
The internet was viewed as easy to access, particularly by younger respondents, but only 34 (14.8%) 
viewed it as trustworthy. Two-thirds considered both pharmacists and GPs easy to understand, in 
contrast to hospital doctors (60; 26.2%).  
Among those experiencing a side effect, 100 (63.3%) were very confident the effect was due to their 
medicine and 44 (27.8%) fairly confident; 31 (19.5%)  had used only one source to confirm their 
view, 50 (31.4%) two sources, 53 (33.3%) three sources and 25 (15.7%) more than three. The actual 
sources used by these respondents differed slightly from their views on the likelihood of using, with 
GPs being used most frequently (68.6%), followed by PILs (66.7%) the internet (37.7%), pharmacists 
(27.7%) then relatives/friends (18.2%). Of the 31 using one information source, 19 accessed a 
healthcare professional, eight used the PIL and four the internet. All but six of those using two or 
more sources accessed a health professional.  Confidence in the association was not associated with 
the number of sources used or with use of a healthcare professional, but was slightly higher among 
those using the internet (p<0.05). 
Conclusion: Most patients experiencing suspected side effects consult a health professional, 
particularly GPs.  PILs and the internet were used more frequently than pharmacists, despite being 
judged less trustworthy than pharmacists. 
